pharma
Home » Archives for pharma
Archimedes snags EMA approval for new pain therapy
Wednesday, September 1st, 2010
Archimedes Pharma says that European regulators have approved PecFent for breakthrough cancer pain as it pushes ahead with plans to
Posted in: Pharma News | 0 Comments »
Read the full story
OTC Drugs and Children
Tuesday, August 31st, 2010
Recently, the news media and Congress focused our attention on the recall of contaminated over-the-counter (OTC) children’s medication manufactured by McNeil Consumer, a division of Johnson & Johnson (see ” Despite Its Social Media Expertise, J&J Fails to Use It Effectively to Communicate to Consumers “). But there’s an even more dangerous problem than contamination relating to OTC medication for children: incorrect dosing.
Posted in: Digital Marketing | 0 Comments »
Read the full story
Endo looks for more acquisitions
Tuesday, August 31st, 2010
Endo Pharmaceuticals’ CEO David Holveck, a Johnson & Johnson alum, is modeling his company after the Big Pharma.
Posted in: Pharma News | 0 Comments »
Read the full story
Alex Butler’s Signature Says It All — Well, Almost All.
Monday, August 23rd, 2010
I am getting excited about presenting at the upcoming DigiPharm Europe 2010 conference in London at the end of September mostly because I will be meeting several pharma people who are doing digital marketing in Europe! One of these people is Alex Butler who is Digital Strategy and Social Media Manager at Janssen-Cilag.
Posted in: Digital Marketing | 0 Comments »
Read the full story
Archimedes starts recruiting for new U.S. headquarters
Monday, August 23rd, 2010
Flush with investment cash and
Posted in: Pharma News | 0 Comments »
Read the full story
Does Lilly need Genzyme more than Sanofi?
Wednesday, August 18th, 2010
Eli Lilly’s latest pipeline setback for Alzheimer’s is adding extra pressure on CEO John Lechleiter to do something dramatic to quickly improve the pharma company’s product mix. And that has BNET ‘s Jim Edwards speculating that Lilly should jump in with a better offer for Genzyme, shoving Sanofi aside.
Posted in: Pharma News | 0 Comments »
Read the full story
FDA approves new emergency contraceptive
Friday, August 13th, 2010
SAN FRANCISCO (MarketWatch) — The U.S. Food and Drug Administration has approved a novel type of emergency contraception pill from closely-held French pharmaceuticals firm HRA Pharma that can prevent unwanted pregnancy for up to five days after sex. Watson Pharmaceuticals Inc
Posted in: headlines | 0 Comments »
Read the full story
CHS, GLG to relocate in Florida
Friday, August 13th, 2010
Two small biotechs hoping to create cancer drugs will move to Jupiter, Florida. CHS Pharma is moving four employees from Miami-Dade County and plans to hire 25 workers over the next five years
Posted in: Pharma News | 0 Comments »
Read the full story
Quarterly Results Suggest Charles River May Have Missed Big With Wuxi
Tuesday, August 3rd, 2010
ChinaBio Today submits: In the aftermath of the breakup of the Charles River Labs (NYSE: CRL ) and WuXi PharmaTech (NYSE: WX ) merger (see story ), the two companies each reported final reports for their respective 2010 second quarter financial performances. The results?
Posted in: Pharma News | 0 Comments »
Read the full story
Where Does the WuXi Deal Breakup Leave Charles River?
Tuesday, August 3rd, 2010
Derek Lowe submits: So when Charles River Laboratories ( CRL ) announced that it was buying WuXi ( WX ), its stock dropped pretty sharply. But unlike many other takeovers, it never recovered, and a lot of the company’s shareholders seem to have continued to be unhappy about the deal.
Posted in: Pharma News | 0 Comments »
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice